Clinical Trials Directory

Trials / Completed

CompletedNCT05274386

Evaluation of the Impact of SpO2 Averaging Time on Performance of an Automatic FiO2 Control System: a Randomized Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Czech Technical University in Prague · Academic / Other
Sex
All
Age
2 Weeks
Healthy volunteers
Not accepted

Summary

The aim of the study is to determine the preferred oximeter averaging setting during automated control of FiO2 (A-FiO2) in infants receiving respiratory support and supplemental oxygen.

Detailed description

There are 7 different averaging time settings available with PRICO (Acutronic Medical Systems AG, Hirzel, Switzerland), but after over a year of experience there is no clear clinical impression of the best setting. Therefore, a small systematic study is needed to determine the optimal guidelines.

Conditions

Interventions

TypeNameDescription
DEVICEFabian ventilator with PRICO system (Acutronic Medical Systems AG, Hirzel, Switzerland); SpO2 averaging time set to 4to6 sThe SpO2 averaging time will be set to 4to6 s for the next 12 hours.
DEVICEFabian ventilator with PRICO system (Acutronic Medical Systems AG, Hirzel, Switzerland); SpO2 averaging time set to 10 sThe SpO2 averaging time will be set to 10 s for the next 12 hours.
DEVICEFabian ventilator with PRICO system (Acutronic Medical Systems AG, Hirzel, Switzerland); SpO2 averaging time set to 16 sThe SpO2 averaging time will be set to 16 s for the next 12 hours.

Timeline

Start date
2022-02-17
Primary completion
2022-12-30
Completion
2022-12-30
First posted
2022-03-10
Last updated
2025-03-25

Locations

1 site across 1 country: Czechia

Source: ClinicalTrials.gov record NCT05274386. Inclusion in this directory is not an endorsement.